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Metabolic syndrome defined by the presence of hyperglycemia, insulin resistance, obesity, hypertension and 
dyslipidemias.This study is about thyroid dysfunction in Sudanese patients with metabolic syndrome. The study 
was conducted in two specialized centers in Khartoum, the first one is Jabir Abu Eliz Specialized Diabetes 
Centre and Quasbaa specialized Diabetes and Endocrine center, in the period from September to December 
2019. The importance of such study is that both condition carry increased cardiovascular risks. The aim of this 
study is to determine the prevalence of thyroid dysfunction among patients with metabolic syndrome in 
Sudanese patients. It also aims at evaluation of metabolic syndrome components in relation to thyroid status. 
The patients with metabolic syndrome were randomly selected during their regular visits to the mentioned 
centers. The diagnosis of metabolic syndrome (MetS) depended on the IDF worldwide used criteria. Thyroid 
function tests were done in all patients. Patients’ history, clinical exam including BP, WC, BMI, record of FBS, 
HbA1c, were all recorded. Obtained data were then analyzed using SPSS software Version 16.  Thyroid 
dysfunction (TD) is a prevalent disorder detected in 38% of Sudanese patients with metabolic syndrome (MetS 
).  Female are more frequently affected (68%) by metabolic syndrome and thyroid dysfunction than men. High 
TSH level is associated with increased BMI in euthyroid patients. TD is common in patients with metabolic 
syndrome. Females are by far more common to develop metabolic syndrome and thyroid dysfunction. Screening 
tests in such patients should be considered for early detection and management to ameliorate cardiovascular 
risks 
Keywords: Thyroid; Dysfunction; Metabolic Syndrome; Sudan. 
1. Introduction 
Jabir Abu Eliz Centre (JADC) was inaugurated in 1998 by the Khartoum state ministry of health as the first 
multidisciplinary specialized diabetic center in the Sudan. It caters for 400000 registered diabetic patients with a 
monthly turn-over of 450 new patients and 200 outpatients per day.   
------------------------------------------------------------------------ 
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It encompasses six surgical clinics, five medical clinics, one clinic for dermatology, medical orthosis, 
ophthalmology and podiatry. Moreover, JADC provides services in health educations, social and psychological 
support. It also provides research opportunities for postgraduate doctors. 
Metabolic syndrome is defined as a clustering of hyperglycemia/ insulin resistance, obesity, hypertension, and 
dyslipidemia which share increased cardiovascular risk and risk of developing type 2 diabetes mellitus (T2DM).  
All these conditions are interrelated and share underlying mediators, mechanisms and pathways [1] With several 
definitions for metabolic syndrome, the World Health Organization considers insulin resistance as central to the 
development of metabolic syndrome. The IDF consensus worldwide definition of the metabolic syndrome 
(2005) is divided into 2 parts: 
 1.2 Part 1 
worldwide definition for use in clinical practice (Depending on these criteria we diagnose our patient in the 
current study) .The consensus statement from the International Diabetes Federation (IDF) defines metabolic 
syndrome as patients having central obesity as identified by waist circumference equal to or more than 94cm for 
the Europid males and equal to or more than 80cm for Europid females with ethnicity specific values for other 
groups, plus any two of the following criteria: 
 Raised Triglyceride (TG) level :> 150 mg/dL( 1.7mmol/L), or specific treatment for this lipid abnormality. 
 Reduced HDL  cholesterol (high density lipoprotein): <40 mg/dL  (1.0mmol/L) in males and < 50 mg/dL  (1.3 
mmol/L) in females 
 Raised blood pressure: systolic BP ≥130 or diastolic BP ≥ 85 mm Hg, or previously diagnosed hypertension 
 Raised fasting plasma glucose (FPG) ≥ 100 mg/dL (5.6 mmol/L), or previously diagnosed type 2 diabetes. If 
above 5.6 mmol/L or 100 mg/dL, OGTT is strongly recommended but is not necessary to define presence of 
the syndrome (IDF consensus, 2005). 
 As the IDF (International Diabetes Fedration) recommended ethnic specific values for the waist circumference, 
in United States of America the ATP III (Adult Treatment Panel III), and the report of National Cholesterol 
Education Program (NCEP) values for the waist circumference (102) cm for males; (88) cm for females are used 
in clinical practice. The consensus advised for the eastern Mediterranean and the Middle East (Arab) 
populations to use European data until more specific data are available.  
1.3Part 2  
‘Platinum standard’ definition—additional metabolic criteria for research. The IDF consensus group has 
highlighted a number of other parameters that appear to be related to the metabolic syndrome which should be 
included in research studies to help determine the predictive power of these extra criteria for CVD and/or 
diabetes.  The use of these additional factors will also allow further modification of the definition. 
The additional metabolic criteria for research include the following: 
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-  Abnormal body fat distribution. 
-Atherogenic dyslipidemia (beyond elevated triglyceride and high-density lipoprotein HDL). 
-Dysglycaemia. 
-Insulin resistance (other than elevated fasting glucose). 
-Vascular dysregulation (beyond elevated blood pressure). 
-Pro-inflammatory state. 
-Pro- thrombotic state. 
-Hormonal factors. 
1.3Metabolic Syndrome the Global Malady 
The prevalence of metabolic syndrome is different in different parts of the world. The condition became the 
major health problem of modern world
[2]
. The incidence of metabolic syndrome parallels the incidence of 
obesity and incidence of type 2 diabetes.  The global survey of obesity which was conducted in 195 countries in 
2015, demonstrated that 604 million adults and 108 million children were obese. The highest prevalence of 
obesity was found in low socio-economic index countries. The study also showed that the prevalence increased 
from 1.1% in 1980 to 3.85% in 2015.
[2]
 Global mortality related to high BMI has increased by 28.3% between 
the years 1990 to 2015. Obesity also was found to cause 120 million disability-adjusted life years. Unfortunately 
the rate is higher in childhood obesity [3].
 
In Sudan according to a study published in 2017 -authors found that the prevalence of obesity was 21.2% and 
women have higher prevalence
 [4]
. The results of the study also showed association between central obesity, 
diabetes and hypertension.  
2. Material and Method 
2.1 Study design 
This is descriptive, analytical, cross-sectional, case control and hospital base study 
2.2 Study area 
This study  carried out in two different centers Jabir Abu Eliz Specialized diabetes Centre and Quasbaa Diabetes 
and Endocrine centre. 
2.3 Study Period 
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 The study was conducted in the period from September to December 2019. 
2.4 Study Population 
 Patients who participate in the study were chosen from those who attend the referral clinic for their regular 
follow up. 
  The patients who fulfill the diagnosis of metabolic syndrome were identified. 
  The diagnosis of MetS was based on IDF criteria.  
 The patients were included in the study after obtaining informed consent on participating on the study. 
 110 patients fulfilled the IDF/National Cholesterol Education Program (NCEP) Panel III criteria for metabolic 
syndrome. 
 Clinical assessment of the patients includes: measurement of blood pressure (BP).  Anthropometric 
measurements such as weight (Wt), height (Ht) were taken using a standard scale.  Stadiometer was used for 
measurement of waist circumference in centimeter (cm) along the mid-point between the costal margin and the 
iliac crest.  Patients’ hospital documents regarding triglyceride (TG), and high density lipoprotein, HbA₁c were 
reported. Blood samples were drawn to be tested for thyroid hormones. Data was collected using designed, 
pretested questionnaire.  
2.5 Inclusion criteria 
 This study includes all patients who fulfill 3 or more of the IDF consensus worldwide definition of metabolic 
syndrome (2006), who agrees to participate in the study. 
2.6 Exclusion Criteria 
-Patients who do not fulfill the IDF criteria. 
- Patients who refuse to participate in this study. 
-Patients less than 18 years. 
-Known cases of thyroid dysfunctions 
2.7 Criteria for the Diagnosis of Metabolic Syndrome 
Patients attending the referral clinic for their regular follow up were examined. Those who met the International 
Diabetes Federation (IDF) criteria for MetS were selected. Patients who have 3 positive criteria were chosen. 
Accordingly, 110 patients fulfilled the criteria. After obtaining informed consent from all the patients, personal 
data was reported from them. Then BP was checked and reported, waist circumference was measured. Body 
mass index (BMI) was calculated using the formula: 
                                                   BMI= weight in (Kg)/ Height in (m²) 
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The patients’ records of Fasting blood glucose, HbA₁c, triglyceride, high density lipoprotein were reported. 
Then blood samples were collected for testing for thyroid hormones.            
 2.8 Blood samples 
  After informed consent, blood sample was collected from the patients.  A local antiseptic (70% ethanol) was 
used to clean the skin. Venous bloods of about (4ml) were withdrawn using a vacationer tube. The collection of 
blood sample was done by well trained lab assistant under supervision of senior lab technologist and medical 
doctor.  The blood was drawn directly into a heparin vacationer tube; the blood sample was centrifuged for 15 
minutes at 3000 rpm after that the serum was separated in a plain container and frozen until it was used for 
analysis of the thyroid function.  
2.9 Methodology 
 •TSH was analyzed based on sandwich immune-enzymometric assay which is a two –site for the quantitative 
determination of the TSH,  using TOSOH  AIA system analyzer. 
•FT4 was analyzed based on competitive enzyme immunoassay used for the quantitative determination of the 
FT4 using TOSOH AIA system analyzer . 
•FT3 was analyzed based on competitive enzyme immunoassay used for the quantitative determination of FT3 
using TOSOH AIA auto-analyzer. 
2.10 Criteria for Diagnosing Thyroid Dysfunction 
Normal TSH range 0.4- 4m IU, Normal FT₃ range 2.17-3.3pg/ml, Normal FT₄ range 0.82-2 ng/dl. 
Overt hypothyroidism is diagnosed with high TSH associated with lower than normal FT₄, FT₃. Subclinical 
hypothyroidism is diagnosed with a high TSH>4m IU, in the presence of normal FT₄, FT₃. 
Hyperthyroidism is diagnosed with low TSH< 0.4 mIU associated with high FT₄, FT₃. Subclinical 
hyperthyroidism is diagnosed with low TSH in the presence of normal FT₄, FT₃. 
 2.11 Statistical Analysis 
SPSS software (version 16) was used for analysis of clinical variables. 
3. Results 
This chapter includes the description and presentation of our findings of the study population including the 
demographic features, components of metabolic syndrome, the levels of thyroid hormones detected by 
investigations, and the statistical analysis of the findings. The total number of patients who fulfilled the IDF 
criteria for metabolic syndrome was 114 patients. 
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3.1 Characteristics of the study population: 
 In the 114 patients with MetS, the number of females was 84 (73.7%) patients and the number of males was 
30 (26.3%), which showed female predominance. This is demonstrated in figure [1] and Table (1). 
 
Figure 1 




 The origin of our patients is demonstrated in figure (2), which showed that most of our patients come from 
central and northern Sudan.  Each region includes 36 patients, accounting for (34%) of the total patients. 30 
(28.6%) patients come from eastern Sudan and only 12 (11.4%) patients from western Sudan. Figure[ 2]. 
 
Figure 2 
Gender Number Percent 
Male 30 27 
Female 84 73 
American Academic Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) (2021) Volume 84, No1, pp 102-117 
108 
 
 The age range of our patients was (24-80) years. The mean age of males was 57.29±10.060. The mean age for 
females was (56.14±10.681) years. Table [2] and [3] demonstrate the distribution of the patients according to 
age.  
Table 2: The Mean age distribution of Patients. 
Age of study  population 
Age (years Mean± STD Minimum Maximum 
 56.46± 10.48 24 80 
Table 3: The Distribution of study population according to age. 
Age of study populationaccording to gender (Mean± STD) P.value 
Age (years Male(N=30) Female (N=84) 0.342 
57.29±10.060 56.14±10.681 
3.2 The Prevalence of Thyroid Dysfunction 
Abnormal TSH level was detected in 44 patients accounting for 38.6 % of the total number of patients. The 
distribution of thyroid status is demonstrated in figure [3]. Most of the patients with TD were females 30 
patients representing 68% of the patients compared to males 14 patients (32%). 
Most of the patients were euthyroid 70 patients (61.4%). Patients with overt hypothyroidism were 7(6.1%), 
hyperthyroidism was detected in 6 patients (5.3%), subclinical hypothyroidism in 15 patients (13.2%), and 
subclinical hyperthyroidism in 16 patients (14%), representing the most prevalent TD in these patients. Figure 
[3] showed the distribution of the study population according to thyroid functions 
 
Figure 3 
If we compare the mean level of thyroid hormones between males and females, we can see that females tend to 
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have higher normal TSH, FT₄ and FT₃ compared to males. This is shown in Table [4].  There is no statistically 
significant difference between the mean values in females and males. 




P value for TSH=0.439, FT₄= 0.71, FT₃=0.329 
3.4The components of Metabolic Syndrome in the study population 
Table [5] demonstrates a comparison of metabolic syndrome components in male and female patients. The 
females tend to have larger in mean BMI (31.6±5.4) compared to males (30.2±3.9), and higher level of HDL ( 
36±8.1) compared to males (32.5±6.5). The male were found to have higher mean triglyceride (158.3±37.6) 
compared to females (149.5±40), and higher mean glycosylated hemoglobin (8.6±1.1) compared to females 
(8.4±1.2). 
Table 5: Comparison of metabolic syndrome parameter according to Gender. 
Parameter Male 





) 30.2±3.9 31.6±5.4 
Triglycerides(mg/dl) 158.3±37.6 149.5±40.6 
HDL(mg/dl) 32.5±6.5 36.0±8.1 
HbA1C (%) 8.6±1.1 8.4±1.2 
Table [6] studies the frequency of different components of metabolic syndrome in the study population in 
addition to the body mass index (BMI).  
Table 6: Distribution of study group according to Frequency of components of metabolic syndrome. 





25<30 31 27.2 
30<35 64 56.1 
35<40 10 8.8 
>40 9 7.9 
Waist Circumference(cm) 88-90 5 4.4 
91- 95 12 10.5 
Parameter Male 
(Mean ± SD) 
Female 
Mean ±SD) 
TSH(IU/ml 2.2±2.8 2.46±.69 
FT4 ng/dl 0.93±0.39 1.08±.72 
FT3 2.5±0.48 2.81±3.8 
American Academic Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) (2021) Volume 84, No1, pp 102-117 
110 
 
96-100 6 5.3 
101-105 23 20.2 
>106 68 59.6 
Systolic Blood Pressure(mm/Hg) <140 77 67.5 
>140 37 32.5 
Diastolic Blood pressure(mm/Hg) <90 78 68.4 
>90 36 31.6 
Fasting Blood sugar(mg/dl) >120 29 25.4 
121-150 52 45.6 
151-180 18 15.8 
>180 15 13.2 
Triglycerides(mg/dl) <150 63 55.3 
>150 51 44.7 
High density lipoprotein(mg/dl) <45 92 80.7 
>45 22 19.3 
The table showed that: 
 BMI range 30<35 was the most frequent weight range found in (64 patients) accounting for 56.1% of study 
group. They fall in obesity class 1 category according to WHO classification of BMI. 
 Waist circumference more than 106 cm was the most frequent findings (68 patients) representing 59.6% of 
the study group. 
 Most of the patients have systolic blood pressure ≤ 140 (77 patient) comprising 67.5% of the study group. 
  Most of the patients have diastolic blood pressure of ≤ 90 (78 patients) representing 68.4% of the study 
group.  
 Most of the patients (52) have a high fasting blood sugar range in the (121-150 mg/dl) comprising 45.6%of 
the study group. Very high levels of more than 180 mg/dl were found in 15 patients (13.2%) 
 Triglyceride of more than 150mg/dl was found in most of the patients (63) accounting for 55.3% of the study 
group. 
 Most of the patients demonstrated low levels of high density lipoprotein HDL 92 patients accounting for 
(80.7%).  
 The most common component of metabolic syndrome in our study group is low HDL (in > 80%), followed by 
the large waist circumference (in 68%). 
3.4 TSH level and the Components of Metabolic Syndrome 
Pearson Correlation was used to determine the association between TSH level in the study population and the 
components of metabolic syndrome in the different thyroid status ( euthyroid, hyperthyroid, and 
hypothyroid).The analysis showed that: 
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 The correlation was only significant between TSH and the BMI in the euthyroid group. This shown table [7]. 
Table 7: Correlation between TSH and Metabolic syndrome parameters in study group with euthyroidism. 





 -0.297 0.570 
Significant (two 
tail) 
0.232 0.018 .627 .315 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
 There is a negative correlation between TSH level and glycated hemoglobin (HbA₁c) in patients with 
hyperthyroidism table [8]. 
Table 8: Correlation between TSH , Metabolic syndrome parameter in study group with Hyperthyroidism. 
Parameter Statistic HBA1C BMI TG HDL 
TSH Pearson 
correlation 
-.001 -.724 -.162 -.484 
Significant (two 
tail) 
.998 .066 .729 .271 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
 Patients with subclinical hypothyroidism showed negative correlation between TSH and the serum 
triglyceride level table [9]. 






Parameter Statistic HBA1C BMI TG HDL 
TSH Pearson 
correlation 
0.380 -0.208 -0.038 0.165 
Significant (two 
tail) 
0.162 0.457 0.894 0.556 
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*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
 The TSH level in the patients with hypothyroidism and subclinical hyperthyroidism has no relation with the 
metabolic syndrome components table [10]. 
Table 10: Correlation between TSH and , Metabolic syndrome parameter in study group with Hypothyroidism. 
Parameter Statistic HBA1C BMI TG HDL 
TSH  Pearson 
correlation 
0.189 0.628 -0.304 0.350 
Significant (two 
tail) 
0.720 0.182 0.558 0.497 
 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed) 
 ANOVA Method: In the last table [11], analysis of variance (ANOVA) was used for comparison of metabolic 
components according to thyroid status. The analysis demonstrated no significant correlation between the 
components of metabolic syndrome and the thyroid state. 

























31.6±5.3 28.5±2.9 28.6±3.2 30±4.9 31.6±4.2 0.385 
HbA1c% 8.4±.9 9.5 ± 2.6 8.6± 1.7 7.6±2.0 8.5±0.79 0.144 
Triglyceride(mg/dl) 152.5±39. 137.3± 37.5 168.8±45 145.1±37.8 159.94± 45.4 0.385 
HDL(mg/dl) 34.3±7.75 35±6.0 34.3±4.7 37.5± 8.8 35.5±8.7 0.688 
 
ANOVA method used for comparison between groups (P value is significant at level of (0.05). 




   The present study evaluates the thyroid dysfunction in patients with metabolic syndrome in Sudanese patients. 
It enrolled 114 patients, taken from two centres in Khartoum. The patients were randomly chosen. All of them 
fulfill three or more of the IDF criteria for diagnosis of metabolic syndrome. Then these patients underwent 
blood investigations for TFT including TSH, FT₃, and FT₄.  
  In this study most of the patients with metabolic syndrome were found to be females (84 patients), equals to 
73% of study population, as shown in table [1] and figure [1]. Some researchers in other studies report a higher 
incidence of the metabolic syndrome in women [5]whereas other studies show higher incidence of the syndrome 
in males. As stated in a review of sex differences in MetS, he reported an accumulating and emerging data that 
support significant heterogeneity  that exists between men and women diagnosed with metabolic syndrome 
possibly due to hormonal regulation of body fat distribution and attendant metabolic abnormalities[6].  
However, other studies demonstrated data from National Health and Nutrition Examination Survey (NHANES) 
(1999-2006) that indicate equal prevalence in both sexes (age adjusted prevalence 34.9% and 33.3% in men and 
women respectively [7]. Another possible cause for the female predominance in our study might be related to 
the ethnic origin. 
Regarding the origin of the patients figure [2] most of the patients come from Northern and central regions of 
Sudan, possibly because these areas are close to these specialized centres. 
 The age range of our study population was 24-80 years Table [2], with an equal mean age of 56 in both males 
and females. This finding is similar to that of other study reported the age range (50-59)[12]. Most of the studies 
demonstrated increase prevalence of metabolic syndrome in all age groups; however the other study  
demonstrated that the most increased prevalence of metabolic syndrome is found in women in the young age 
group which is different from our study population[6]. 
 The prevalence of thyroid dysfunction (TD) in the present study population was found to be 38.6%. This 
prevalence is higher than the prevalence of TD reported other area in which the prevalence are  (28%), and 
(31.9%)[9,10]. The increased prevalence in Sudanese patients in the present study may be related to iodine 
deficiency this agree with  previous study which described iodine deficiency disorders (IDD) throughout the 
urban areas in the Sudan due to iodine deficiency. [7] 
  Among the 44 patients with TD in this study group the females were 30 representing 68% of cases whereas the 
males were 14 patients (32%). The female dominance was also described in two different studies ,the  first  
reported  that  39.7% of patients were  females compared with 26 % males, and the second study  reported that  
75% of patients were  females versus 25% males.[9] 
The main categories of thyroid status were shown in figure [3]. Most of the patients were found to be euthyoid 
(61.4%). Overt hypothyroidism was found in 6.1% of the study group which is much less than the frequency 
reported by another study which was 17.59% [9]. In our study the subclinical hypothyroidism was detected in 
13.2% which is slightly higher than that of other study which reported that subclinical hypothyroidism was 
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8.1%. Also, the subclinical hyperthyroidism was the highest frequency in our study group 14% compared to 
0.7% reported by same author. This finding is different from all of the reviewed studies all over the world that 
reported the subclinical hypothyroidism as the most prevalent TD among those with MetS. It could be due to 
other causes such as auto-antibodies or to abnormal iodine levels in these patients which was not measured in 
our study. [9] 
 In the present study cases with patients with overt hyperthyroidism constitute about 6.1% of the study group 
which is different from the findings reported by other studies the first study  reported no case with overt 
hyperthyroidism[9] or another  study which  reported overt hyperthyroidism in a single case out of the 300 of 
the study group [10]. The high percentage of hyperthyroidism in our patients may be due to the presence of 
auto-antibodies [11]. 
Table [4] demonstrated a comparison between the mean levels of thyroid hormones in both males and females. 
It showed that there is higher mean level in all thyroid hormones in females’ patients. This information may be 
of importance regarding the management of females with thyroid disorder.  
The gender differences of the components of metabolic syndrome in our patients are shown in table [5]. The 
mean BMI was higher in females a finding similar to that reported by other [12]. The females in our study 
population also demonstrate tighter blood sugar control. This finding is different from that reported by 
mentioned study [12]. The females in our study group also tend to have lower TG and higher HDL levels which 
is disagree with the findings reported the by other study [9] 
Table [6] demonstrates the frequency of different components of metabolic syndrome in the study population. 
About 60% of the study population have waist circumference of more than 106cm representing the second most 
common component of metabolic syndrome. Another study reported central obesity as the most prevalent 
component of metabolic syndrome in Moraccan patients [13]. Previous study also showed the central obesity 
was the most prevalent component in the study population [13].  The most prevalent component of MetS in our 
study group was the low HDL (80.7%), this finding is almost typical of that reported by other authors who 
reported low HDL in 82.78% of the population of Bamboutos Division, West region of Cameroon. Other 
metabolic components in our study population include High triglyceride in 55.3%, hyperglycaemia in 45.6%. 
High Systolic blood pressure detected in 32.5% and high diastolic blood pressure in 31.6%. [13,14] 
The relation between TSH levels and the different components of metabolic syndrome was studied using 
Pearson Correlation. This is shown in table [11]. The analysis in our study population demonstrates a positive 
correlation between TSH level and the BMI in patients with euthyroid state, which was the only positive 
association.The positive correlation was found between TSH level and central obesity in the previous study [14]. 
The same authors also reported association between TSH level and HDL-C [14]. Another study showed high 
normal TSH level this had been significantly associated with the component of metabolic syndrome [15], but is 
different from the findings reported by others who found no association between TSH level and metabolic 
components in the euthyroid state [9]. 
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Figure [8,9,10] demonstrate the relation between TSH level in the study group and the different components of 
metabolic syndrome. The statistical analysis showed no significant correlation between them. This is also true 
for the finding by others study  which  did not find association between TSH level and MetS components in 
euthyroid and subclinical hypothyroidism [16]. 
When ANOVA method was used in our study group to compare the different groups, table [15], the analysis 
demonstrates no association between the different groups of TD and the components of metabolic syndrome. 
This finding is similar to that reported in the study by other as they found no association between TSH level and 
metabolic syndrome or its components, HOMA-IR, serum insulin or serum high-sensitivity CRP (hs-CRP)[17]. 
The absence of correlation between TD and MetS components was also reported by another study using the 
same method of analysis as in our study [10]. 
4. Conclusion 
 Thyroid dysfunction is a prevalent disorder in Sudanese patients with metabolic syndrome. 
  Metabolic syndrome as well as thyroid dysfunction is more common in Sudanese women. 
 The mean age affected by metabolic syndrome is 56 years in both sexes. 
 The most prevalent thyroid dysfunction in Sudanese patients with metabolic syndrome is subclinical 
hyperthyroidism 
5. Recommendations 
 As thyroid disorders are common in patients with metabolic syndrome, screening tests for thyroid dysfunction 
are recommended in patients with metabolic syndrome (MetS). 
 Patients’ education and early detection and treatment of thyroid disorders in patients with metabolic syndrome 
(MetS) are vital to mitigate cardiovascular risks. 
 Population based studies of thyroid dysfunction in patients with metabolic syndrome (MetS) for early 
detection and management. 
6. Limitations of this study 
Limitations of the study: this study was conducted in endocrine specialized centers with a small sample size , 
which might  not reflect the real community statistics, however it draw our attention for the emerging global 
problem of obesity and metabolic syndrome and its complications. Also the study has been conducted in Sudan 
where recent studies showed that  there is iodine deficiency all over  the country, this fact may  influence the 
results of thyroid  blood tests. Other constrains to the study are lack of other thyroid investigations like thyroid 
auto -antibodies. Also the use of metformin in some patients participating in this study was not considered , a 
known effect of metformin on TFT is elevation of TSH.   
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